杭州默佳生物科技有限公司

English

¦

中文

Hangzhou Mojia Bio-technology co., LTD

自由容器

Product Center

Allergens

Quality product

Respiratory viruses

自由容器(1)

News

Premier calls for deepening health reform

Chinese Premier Li Keqiang on Tuesday called for deepening coordinated reform of medical services, health insurance, and the pharmaceutical industry.

Understanding Precision Medicine in Cancer Treatment

Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on agenetic understanding of their disease. This may also be called personalized medicine. The idea of precision medicine is not new, but recent advances in science and technology have helped speed up the pace of this area of research.

PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding shares being acquired will be approximately $1.3 billion in cash.

自由容器

Forefront

Home About Us Product LIS News Center Contact Us

mj_biotech@163.com

400-850-3018

The 12th floor of boshi 8, west city, hangzhou, zhejiang province,china

website qrcode

Mobile version